share_log

智飞生物(300122.SZ):研发管线内的呼吸道合胞病毒(RSV)疫苗目前处于临床前研究阶段

Chongqing Zhifei Biological Products (300122.SZ): Respiratory syncytial virus (RSV) vaccine in the R&D pipeline is currently in the preclinical research stage.

Gelonghui Finance ·  Jun 14 04:40

On June 14, Gelonhui reported that an investor asked Chongqing Zhifei Biological Products (300122.SZ) on the investor interaction platform, "May I ask at what stage the company's RSV vaccine research and development is at?" The company replied that the respiratory syncytial virus (RSV) vaccine in its research and development pipeline is currently in the preclinical stage.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment